Skip to content
sugarisadrug.com
  • Home
  • Diabetes
  • Health News
  • General Sugar
  • Food Choices
  • Insulin
  • Mental Health
  • Stop Eating Sugar
  • Stop Killing Yourself
  • Fructose
  • Sugar Science

Month: June 2026

1152-OR: ABC Transporters as Surrogate Biomarkers of HDL Functionality for Early Atherosclerosis Risk Assessment in Type 2 Diabetes Mellitus

June 15, 2026 by sugaradmin

Introduction and Objective: In type 2 diabetes mellitus (T2DM) with atherosclerosis, high-density lipoprotein cholesterol (HDL-C) levels may appear normal, but may exhibit reduced functionality. ATP-binding cassette transporters play a crucial role in HDL functionality, but there are only a few clinical studies. We evaluated the levels of ABC transporters (ABCA1 and ABCG1) in T2DM compared […]

Read More
DiabetesLeave a Comment on 1152-OR: ABC Transporters as Surrogate Biomarkers of HDL Functionality for Early Atherosclerosis Risk Assessment in Type 2 Diabetes Mellitus

1173-OR: Real-World Evaluation of the Implantable One-Year Eversense 365 CGM System

June 15, 2026 by sugaradmin

Introduction and Objective: A real-world assessment of the 1-year implantable Eversense 365 CGM System was conducted in adults with diabetes using open-loop insulin regimens.Methods: Anonymized sensor glucose (SG) data from the Eversense Data Management System (DMS) for the first 8277 sensors in the US were used to compare glucometrics from the 1st and 2nd 6-months […]

Read More
DiabetesLeave a Comment on 1173-OR: Real-World Evaluation of the Implantable One-Year Eversense 365 CGM System

1151-OR: Exosomes Derived from Genetically Modified Bone Marrow Derived Mesenchymal Stromal Cells (BM-MSCS) Inhibit Adipogenesis

June 15, 2026 by sugaradmin

Introduction and Objective: Obesity associated with type 2 diabetes (T2DM) is known to cause white adipose tissue hyperplasia associated with oxidative stress. Stem/ progenitor cell therapy may provide a novel strategy for treating obesity- and diabetes-related complications. Our laboratory has shown success in using p53-silenced endothelial progenitor cells (EPCs) in disease models such as hyperglycemia-associated […]

Read More
DiabetesLeave a Comment on 1151-OR: Exosomes Derived from Genetically Modified Bone Marrow Derived Mesenchymal Stromal Cells (BM-MSCS) Inhibit Adipogenesis

1185-OR: Mechanisms of Early-Onset Prediabetes in Women after Pregnancy

June 15, 2026 by sugaradmin

Introduction and Objective: Gestational diabetes mellitus (GDM) increases the risk of early-onset prediabetes (<40 years). We hypothesized that biological pathways mediating the transition from pregnancy to early-onset prediabetes one year postpartum differ between women with prior GDM and those with normoglycemic (NG) pregnancies, using stratified longitudinal analyses with deep metabolic phenotyping.Methods: In the prospective, multicenter […]

Read More
DiabetesLeave a Comment on 1185-OR: Mechanisms of Early-Onset Prediabetes in Women after Pregnancy

1166-OR: The Natural History of Type 2 Diabetes Varies between Clinical Subphenotypes of At-Risk Individuals

June 15, 2026 by sugaradmin

Introduction and Objective: The natural history of type 2 diabetes (T2D) is characterized by a gradual decrease of insulin sensitivity and characteristically a steep decline of beta cell function short before diagnosis. However, recent data-driven sub-phenotyping has unveiled high-risk clusters of individuals with increased T2D risk, that differ profoundly in body fat distribution, insulin resistance […]

Read More
DiabetesLeave a Comment on 1166-OR: The Natural History of Type 2 Diabetes Varies between Clinical Subphenotypes of At-Risk Individuals

1154-OR: Vascular Age Gap Based on Carotid Intima-Media Thickness as a Marker of Early Vascular Aging in Adults with Type 1 Diabetes and Its Association with Diabetic Complications

June 15, 2026 by sugaradmin

Introduction and Objective: Early vascular aging (EVA), based on vascular age gap (VAG), reflects excess vascular aging beyond chronological age, but its clinical relevance in type 1 diabetes (T1D) remains unclear. We aimed to characterize EVA based on carotid intima-media thickness (cIMT) and its associations with microvascular complications in adults with T1D.Methods: This cross-sectional study […]

Read More
DiabetesLeave a Comment on 1154-OR: Vascular Age Gap Based on Carotid Intima-Media Thickness as a Marker of Early Vascular Aging in Adults with Type 1 Diabetes and Its Association with Diabetic Complications

1219-OR: Effects of Mifepristone in People with Difficult-to-Control T2D and Hypercortisolism on GLP-1RAs

June 15, 2026 by sugaradmin

Introduction and Objective: Hypercortisolism may reduce the efficacy of GLP-1 RAs or tirzepatide by disrupting the incretin system, impairing beta cell function, and inducing insulin resistance. The CATALYST trial studied the prevalence and medical treatment of hypercortisolism in people with difficult-to-treat T2D. This sub-analysis assessed treatment with mifepristone (mife) in participants on GLP-1 RAs or […]

Read More
DiabetesLeave a Comment on 1219-OR: Effects of Mifepristone in People with Difficult-to-Control T2D and Hypercortisolism on GLP-1RAs

1158-OR: Preprocedural Neutrophil Percentage–to–Albumin Ratio Predicts One-Year Major Adverse Cardiovascular Events in Patients with Lower Extremity Arteriosclerosis Obliterans Undergoing Endovascular Revascularization

June 14, 2026 by sugaradmin

Introduction and Objective: The neutrophil percentage-to-albumin ratio (NPAR) is a novel inflammatory marker linked to adverse cardiovascular outcomes. Its prognostic value in patients with lower extremity arteriosclerosis obliterans (LEASO) undergoing endovascular revascularization remains unclear. This study aimed to investigate the association between preprocedural NPAR and 1-year major adverse cardiovascular events (MACEs).Methods: A prospective cohort study […]

Read More
DiabetesLeave a Comment on 1158-OR: Preprocedural Neutrophil Percentage–to–Albumin Ratio Predicts One-Year Major Adverse Cardiovascular Events in Patients with Lower Extremity Arteriosclerosis Obliterans Undergoing Endovascular Revascularization

1207-OR: Early Plasma Metabolomic Adaptation during Dietary Interventions for Long-Term Weight Loss Success and Improved Cardiometabolic Health

June 14, 2026 by sugaradmin

Introduction and Objective: Maintaining long-term weight loss is challenging, and the underlying mechanisms remain unclear due to substantial individual variability. We developed a Metabolomic Adaptation Response (MAR) Index that integrates early metabolomic changes to predict long-term weight loss and examined whether plasma microRNAs from key metabolic organs influence the MAR.Methods: Untargeted plasma metabolomics were performed […]

Read More
DiabetesLeave a Comment on 1207-OR: Early Plasma Metabolomic Adaptation during Dietary Interventions for Long-Term Weight Loss Success and Improved Cardiometabolic Health

1190-OR: Role of Immune Microenvironment in Age-Related Decline of Brown Adipose Tissue

June 14, 2026 by sugaradmin

Introduction and Objective: Brown adipose tissue (BAT) presents a promising target to combat obesity and metabolic diseases. In humans, BAT mass and activity substantially decline with aging. However, the mechanisms underlying the age-related decline in BAT remain poorly understood. Due to their genetic and physiological similarities to humans, non-human primates (NHPs) provide a powerful model […]

Read More
DiabetesLeave a Comment on 1190-OR: Role of Immune Microenvironment in Age-Related Decline of Brown Adipose Tissue

Posts navigation

Older posts
Newer posts

Recent Posts

  • Sex Differences in ER Stress Pathways Are a Key Determinant of β-Cell Proliferation and Resilience
  • β-Hydroxybutyrate Improves Glucose Metabolism in Streptozotocin-Induced Type 1 Diabetes by Inhibiting Gut and Liver Glucose Transporters via GPR109A
  • Comment on Sakaki et al. From Disease Staging to Early Graft Assessment in β-Cell Replacement Therapy
  • Diabetes Spotlight: Rana Gupta, PhD—Developmental Biology and Adipose Tissue
  • Response to Comment on Sakaki et al. Quantitative β-Cell Mass Imaging Redefines Disease Staging and Glycemic Control in Type 1 Diabetes

Recent Comments

  • A WordPress Commenter on SUCROSE: “PURE” ENERGY AT A PRICE

Archives

  • June 2026
  • May 2026
  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • November 2024
  • October 2024
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • May 2017

Categories

  • Celebrity Health
  • Diabetes
  • Food Choices
  • Fructose
  • General Sugar
  • Glucose
  • Health News
  • Insulin
  • Mental Health
  • Natural Unrefined Sugar
  • Stop Eating Sugar
  • Stop Killing Yourself
  • Sucrose
  • Sugar Science

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org
  • Home
  • Diabetes
  • Health News
  • General Sugar
  • Food Choices
  • Insulin
  • Mental Health
  • Stop Eating Sugar
  • Stop Killing Yourself
  • Fructose
  • Sugar Science

© 2026 Sugar is a DRUG | Sugar Addiction Awareness